|Day Low/High||6.97 / 7.32|
|52 Wk Low/High||3.32 / 14.65|
TGR-1202 (umbralisib) selected as the PI3K Delta inhibitor to be used in this multiple arm comparison study
Investor Conference Call to be Held Today, Wednesday, November 8, 2017 at 8:30am ET
Investor Conference Call to be held Wednesday, November 8, 2017 at 8:30am ET
Investor and Analyst Reception to be Held on Sunday December 10, 2017 at 8:00pm ET at the Ritz Carlton Atlanta (Downtown) with Presentations by Leading Clinical Investigators
Investors eyeing a purchase of TG Therapeutics Inc shares, but tentative about paying the going market price of $8.28/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $5 strike, which has a bid at the time of this writing of $1.05.
Follow-up meeting with FDA expected before year end
Enrollment expected to continue until mid-October to allow patients already identified an opportunity to participate in the trial
Prospects for acquisition activity in the sector are improving.
Investor Conference Call to be Held Today, Wednesday, August 9, 2017 at 8:30am ET
Investor Conference Call to be held Wednesday, August 9, 2017 at 8:30am ET
Investors in TG Therapeutics Inc saw new options begin trading today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain for the new September 15th contracts and identified one put and one call contract of particular interest.
The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 2,433,158 share increase in total short interest for TG Therapeutics Inc , to 17,111,572, an increase of 16.58% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Jim Cramer is bullish on Lockheed Martin, TG Therapeutics, and HD Supply.
Growth is crushing value, says Jim Cramer, and the dynamic is more pronounced in individual sectors.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.